Clinical Trial of PCV13 in Infants Aged Approximately 2 Months (42 to 89 Days)

PREVNAR 13 (pneumococcal 13-valent conjugate vaccine) - Pfizer

13-valent pneumococcal polysaccharide conjugate vaccine (PCV13i) - Sinovac, CanSino

http://clinicaltrials.gov/ct2/show/NCT07593924

May 19, 2026